'Glibenclamide  and Metformin HCI'

Glibenclamide  and Metformin HCI
GLIBEMIDE FORTE  are two commonly prescribed medications for the management of type 2 diabetes mellitus. Let's explore each medication:
Glibenclamide:
Glibenclamide belongs to a class of medications called sulfonylureas. GLIBEMIDE FORTE  works by stimulating the pancreas to produce more insulin and helps improve insulin action in the body.
Glibenclamide primarily targets the reduction of fasting blood sugar levels by increasing insulin secretion from the pancreas.
GLIBEMIDE FORTE  is usually taken orally as a tablet once or twice daily, depending on the prescribed dosage and formulation.
Glibenclamide should be taken with meals to minimize the risk of low blood sugar levels (hypoglycemia).
Regular monitoring of blood sugar levels is important to ensure optimal control and avoid hypoglycemia.
Metformin HCI:
Metformin HCI is a medication classified as a biguanide. It works by reducing glucose production in the liver and improving insulin sensitivity in the body's cells.
Metformin HCI primarily targets the reduction of fasting blood sugar levels and also helps to lower postprandial (after-meal) blood sugar levels.
GLIBEMIDE FORTE  is typically taken orally as a tablet, often with meals, to minimize gastrointestinal side effects.
Metformin HCI is usually started at a low dose and gradually increased as tolerated.
Side effects of Metformin HCI can include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal discomfort. These side effects are usually temporary and improve with time.
Combination Therapy:
Glibenclamide and Metformin HCI can be prescribed together as a combination therapy for individuals with type 2 diabetes who are not achieving adequate blood sugar control with either medication alone.
Combining these medications can provide complementary effects on blood sugar control by targeting different mechanisms.
Glibenclamide enhances insulin secretion, while Metformin HCI improves insulin sensitivity and reduces glucose production in the liver.
GLIBEMIDE FORTE  combination therapy allows for lower doses of each medication, potentially reducing the risk of side effects.
For further information please contact:
info@sterispharma.com
order now: - https://www.sterisonline.com/product/glibemide-forte-133416